TY - JOUR
T1 - New psychological therapies for irritable bowel syndrome
T2 - Mindfulness, acceptance and commitment therapy (ACT)
AU - Sebastián Sánchez, Beatriz
AU - Gil Roales-Nieto, Jesús
AU - Ferreira, Nuno B.
AU - Gil Luciano, Bárbara
AU - Sebastián Domingo, Juan José
PY - 2017/9/1
Y1 - 2017/9/1
N2 - The current goal of treatment in irritable bowel syndrome (IBS) focuses primarily on symptom management and attempts to improve quality of life. Several treatments are at the disposal of physicians; lifestyle and dietary management, pharmacological treatments and psychological interventions are the most used and recommended. Psychological treatments have been proposed as viable alternatives or compliments to existing care models. Most forms of psychological therapies studied have been shown to be helpful in reducing symptoms and in improving the psychological component of anxiety/depression and health-related quality of life. According to current NICE/NHS guidelines, physicians should consider referral for psychological treatment in patients who do not respond to pharmacotherapy for a period of 12 months and develop a continuing symptom profile (described as refractory irritable bowel syndrome). Cognitive behavioral therapy (CBT) is the best studied treatment and seems to be the most promising therapeutic approach. However, some studies have challenged the effectiveness of this therapy for irritable bowel syndrome. One study concluded that cognitive behavioral therapy is no more effective than attention placebo control condition and another study showed that the beneficial effects wane after six months of follow-up. A review of mind/body approaches to irritable bowel syndrome has therefore suggested that alternate strategies targeting mechanisms other than thought content change might be helpful, specifically mindfulness and acceptance-based approaches. In this article we review these new psychological treatment approaches in an attempt to raise awareness of alternative treatments to gastroenterologists that treat this clinical syndrome.
AB - The current goal of treatment in irritable bowel syndrome (IBS) focuses primarily on symptom management and attempts to improve quality of life. Several treatments are at the disposal of physicians; lifestyle and dietary management, pharmacological treatments and psychological interventions are the most used and recommended. Psychological treatments have been proposed as viable alternatives or compliments to existing care models. Most forms of psychological therapies studied have been shown to be helpful in reducing symptoms and in improving the psychological component of anxiety/depression and health-related quality of life. According to current NICE/NHS guidelines, physicians should consider referral for psychological treatment in patients who do not respond to pharmacotherapy for a period of 12 months and develop a continuing symptom profile (described as refractory irritable bowel syndrome). Cognitive behavioral therapy (CBT) is the best studied treatment and seems to be the most promising therapeutic approach. However, some studies have challenged the effectiveness of this therapy for irritable bowel syndrome. One study concluded that cognitive behavioral therapy is no more effective than attention placebo control condition and another study showed that the beneficial effects wane after six months of follow-up. A review of mind/body approaches to irritable bowel syndrome has therefore suggested that alternate strategies targeting mechanisms other than thought content change might be helpful, specifically mindfulness and acceptance-based approaches. In this article we review these new psychological treatment approaches in an attempt to raise awareness of alternative treatments to gastroenterologists that treat this clinical syndrome.
KW - Acceptance and commitment therapy
KW - Cognitive therapy
KW - Irritable bowel syndrome
KW - Mental disorders
KW - Mindfulness
KW - Psychotherapy
UR - http://www.scopus.com/inward/record.url?scp=85042045193&partnerID=8YFLogxK
U2 - 10.17235/reed.2017.4660/2016
DO - 10.17235/reed.2017.4660/2016
M3 - Review article
C2 - 28724306
AN - SCOPUS:85042045193
SN - 1130-0108
VL - 109
SP - 648
EP - 657
JO - Revista Espanola de Enfermedades Digestivas
JF - Revista Espanola de Enfermedades Digestivas
IS - 9
ER -